Human placental connective tissue implants to augment damaged tissue.

 
CTM Products
 
02.png

TECHNOLOGY

Connective tissue contains functional ECM components that support constructive remodeling1 .

 

CTM develops and creates immune-privileged Connective Tissue and ExtraCellular Matrix (ECM) structural implants. Our products are designed to cover or protect tissues intra-operatively and to augment or replace damaged or inadequate tissue at the surgical site.

ExtraCellular Matrix

The ECM is a combination of both structural and functional components including collagens, glycoproteins, proteoglycans, mucins, elastic fibers, and growth factors2 that form a three-dimensional matrix, providing structural support to the body’s tissues and cells.3

 

 

Constructive remodeling is the body's process of forming site-appropriate, functional tissue.1

 
 
Dermis, Tendon, Ligament
 
 

Injuries can lead to significant tissue damage, and even after surgical repair these sites often lack adequate functional tissue to remodel successfuly. This can result in post-operative complications, failure, or re-injury. In order to augment the tissue damage, surgeons look to the most native tissue options to increase the likelihood of successful repair.

Connective tissue is the most prolific tissue type, and is ubiquitous throughout the body. This allows us to create an ideal ECM implant option to augment tissue damage and support constructive remodeling in a diverse range of surgical sites.

 
Screen Shot 2019-08-15 at 4.46.25 PM.png
 

A SURGICAL SOLUTION

CTM helps physicians deal with issues that are beyond their control.

 
 
Gray-Line-02.png

01

Augment damaged tissue with functional tissue

Gray-Line-02.png

02

Provide structural support at the surgical site

Gray-Line-02.png

03

Support the body's constructive remodeling process

 
 
02.png

PRODUCTS

Ideal options designed for any surgical approach.

 
Inject

Inject

Pack, Fill, Spread

Pack, Fill, Spread

Wrap, Cover, Protect

Wrap, Cover, Protect

 

 

STORAGE & HANDLING

5 year shelf life
Store at ambient temperature
Sterilized by irradiation
Single patient, one-time use only
Only for use by a registered physician

 

 

INTENDED USE

CTM implants are intended for homologous use to cover or protect4, or to supplement or replace damaged or inadequate connective tissue.5

 

White-02.jpg

CONTACT US FOR MORE INFORMATION

By submitting this form, you agree to receive text messages from CTM Biomedical related to the nature of your request or submission. Message and data rates may apply. Message frequency varies. Reply HELP for help and STOP to cancel. View Terms of Service and Privacy Policy.

 

References: (1.) Brown, BN, Badylak, SF. Extracellular matrix as an inductive scaffold for functional tissue reconstruction. Transl Res. 2014 April ; 163(4): 268–285. doi:10.1016/j.trsl.2013.11.003. (2.) Hynes RO, Naba A. Overview of the matrisome–an inventory of extracellular matrix constituents and functions. Cold Spring Harbor Perspect Biol. 2012; 4:a004903. (3.) Badylak, SF, Freytes, DO, Gilber, TW. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater. 5 (2009) 1–13. (4.) Reference on file with CTM Biomedical. (5.) Reference on file with CTM Biomedical.

White-02.jpg